Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

 
 
Session Overview
Session
Nanotechnology in photosensitizer delivery
Time:
Thursday, 13/July/2023:
11:00am - 1:00pm

Session Chair: Girgis Obaid
Session Chair: Anine Crous
Location: Duetto

Tampere Hall, 2nd level

Show help for 'Increase or decrease the abstract text size'
Presentations
11:00am - 11:15am

Unraveling the effects of photochemical internalization of oxaliplatin by X-ray fluorescence-based elemental imaging

Nazareth Milagros Carigga Gutierrez1, Tristan Le Clainche1, Malika Dakir1, Sylvain Bohic2, Jean-Luc Coll1, Mans Broekgaarden1

1Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Grenoble-Alpes University, Grenoble, France.; 2European Synchrotron Radiation Facility, Grenoble, France.



11:15am - 11:30am

PDT hydrogel for controlled cargo release from hydrogel-bound liposomes.

Olga Lem1, Alexander Efimov1, Nikita Durandin1, Timo Laaksonen1,2

1Tampere University, Finland; 2Helsinki University, Finland



11:30am - 11:45am

Preliminary study on vascular-targeted polyphenol nanoparticles in photodynamic therapy of port-wine stains

Lihua Yang1,2, Lian Liu1,2, Qiulan Tong3, Xian Jiang1,2

1Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China; 2Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China; 3Engineering Research Center in Biomaterials and National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China



11:45am - 12:00pm

Nano therapy for photodynamic cancer treatment of lung, melanoma and cervical cancer stem cells

Anine Crous, Heidi Abrahamse

University of Johannesburg, South Africa



12:00pm - 12:15pm

Optimization and Evaluation of Nanoparticle Verteporfin Formation

Kaylin Baumiller1, John Quinlan1,2, Idrisa Rahman1,2, Huang Chiao Huang1

1Fischell Department of Bioengineering, University of Maryland, MD, USA; 2Laboratory of Cellular Biology, National Institutes of Health, Bethesda, MD, USA



12:15pm - 12:30pm

Combining light-activatable nanotechnology and fluorescence-guided intervention to treat tumors

Barry J. Liang1,2, Sumiao Pang1, Robert Perttilä3, Chen-Hua Ma1, Payal Srivastava1, Brandon Gaitan1, Aaron J. Sorrin1, Nada Fadul1, Zoe Ylöniemi3, Dana M. Roque4,5, Tayyaba Hasan6, Petteri Uusimaa3, Huang-Chiao Huang1,4

1Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742, USA; 2Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; 3Modulight Corp, Tampere, Finland; 4Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA; 5Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore 21201 MD, USA; 6Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA



12:30pm - 12:45pm

A versatile and environmentally friendly formulation for porphyrins: lignin nanoparticles and their application in photodynamic antimicrobial chemotherapy

Nidia Maldonado-Carmona1,2,3, Tan-Sothea Ouk1, Nicolas Villandier1, Mário J.F. Calvete2, Mariette Pereira2, Stéphanie Leroy-Lhez1

1LABCiS Laboratory, Faculty of Sciences and Techniques, University of Limoges, Limoges, France; 2Coimbra Chemistry Center, Department of Chemistry, University of Chemistry, Coimbra, Portugal; 3Current affiliation: Sorbonne Université, Centre National de la Recherche Scientifique, Laboratoire Jean Perrin, Paris, France



12:45pm - 1:00pm

Targeted Photodynamic Therapy using a Novel Vectorized Photosensitizer coupled to a Folic Acid Analog Induces Tumor Cell Death and Pro-Inflammatory Inhibition in a Model of Ovarian Cancer

Léa Boidin1, Margaux Merlier1, Morgane Moinard2, Martha Baydoun1, Laurine Ziane1, Anthony Lefebvre1, Guillaume Grolez1, Yohan Kerbage1,3, Samir Acherar4, Céline Frochot2, Olivier Morales1,5, Nadira Delhem1

1Université de Lille, Inserm, CHU Lille, U1189-ONCO-THAI – Assisted Laser Therapy and Immunotherapy for Oncology, France; 2Université de Lorraine, UMR 7274 CNRS, Laboratoire réactions et génie des procédés (LRGP), 54000 Nancy, France; 3Hôpital Jeanne de Flandre, Chirurgie Gynécologique Obstétrique, CHU de Lille, France; 4Université de Lorraine, UMR CNRS 7375 Laboratoire de Chimie Physique Macromoléculaire (LCPM), 54000 Nancy, France; 5CNRS UMS 3702 IBL, F 59000 Lille, France



 
Contact and Legal Notice · Contact Address:
Privacy Statement · Conference: IPA 2023
Conference Software: ConfTool Pro 2.8.101+TC
© 2001–2024 by Dr. H. Weinreich, Hamburg, Germany